TD ASSET MANAGEMENT INC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$478,000
+51.7%
50,100
+47.8%
0.00%
Q2 2021$315,000
-43.0%
33,900
-25.9%
0.00%
-100.0%
Q3 2018$553,000
-71.7%
45,769
-63.5%
0.00%
-66.7%
Q2 2018$1,956,000
+19.0%
125,227
+14.5%
0.00%0.0%
Q1 2018$1,644,000
-47.5%
109,327
-49.8%
0.00%
-40.0%
Q4 2017$3,133,000
-7.9%
217,754
-3.4%
0.01%0.0%
Q3 2017$3,400,000
+178.7%
225,454
+86.1%
0.01%
+150.0%
Q2 2017$1,220,000
+36.2%
121,160
-3.6%
0.00%
+100.0%
Q1 2017$896,000
+25.7%
125,660
-12.4%
0.00%0.0%
Q4 2016$713,000
-23.1%
143,460
+14.5%
0.00%
-50.0%
Q3 2016$927,000
-1.4%
125,260
-27.2%
0.00%0.0%
Q2 2016$940,000
-35.9%
172,100
-0.9%
0.00%
-33.3%
Q1 2016$1,467,000
-15.3%
173,600
-2.9%
0.00%0.0%
Q4 2015$1,733,000
-29.7%
178,700
+1.5%
0.00%
-40.0%
Q3 2015$2,464,000
+1.1%
176,100
+2.2%
0.01%
+25.0%
Q2 2015$2,438,000172,3000.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders